The Therapeutic Potential of Novel and Emerging Anti-fibrotic Drugs

Deadline for manuscript submissions: 30 March 2026.

Guest Editors (3)

Jane  Bourke
Dr. Jane Bourke 
Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, 3168, VIC, Australia
Interests: Airway; Bronchodilator; Precision Cut Lung Slice; Asthma; Fibrosis; Silicosis; COPD; Pharmacology
Chrishan S.  Samuel
Prof. Chrishan S. Samuel 
Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC, Australia
Interests: Cardiovascular Fibrosis; Kidney Fibrosis; Airway/Lung Fibrosis; Peptide therapeutics; Stem Cells; Epithelial Repair Factors; Animal Models; Myofibroblast Signal Transduction
Robert  Widdop
Prof. Robert Widdop 
Cardiovascular Disease Program, Monash Biomedicine Discovery Institute, and Department of Pharmacology, Monash University, Clayton VIC, Australia
Interests: Renin Angiotensin System; Hypertension; Cardiovascular Disease; Renal Disease;  Fibrotic Biomarkers

Topic Collection Information

Published Papers (0 papers)

TOP